{"result": "(\"entity\"<|>NUTRITIONAL FACTORS<|>EVENT<|>Nutritional factors contributing to the development of cholestasis during total parenteral nutrition are discussed in a paper by Forchielli ML and Walker WA.)\n##\n(\"entity\"<|>LONG-TERM OUTCOME<|>EVENT<|>The long-term outcome of children receiving home parenteral nutrition is studied in a 20-year single-center experience in 302 patients by Colomb V et al.)\n##\n(\"entity\"<|>SYSTEMATIC REVIEW<|>EVENT<|>A systematic review on parenteral nutrition-associated cholestasis was conducted by Rangel SJ et al.)\n##\n(\"entity\"<|>CASE SERIES<|>EVENT<|>A case series on central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients was reported by Wong T et al.)\n##\n(\"entity\"<|>HEPARIN-CONTROLLED PROSPECTIVE TRIAL<|>EVENT<|>A heparin-controlled prospective trial on taurolidine lock effectiveness in preventing catheter-related bloodstream infections was conducted by Bisseling TM et al.)\n##\n(\"entity\"<|>REVIEW<|>EVENT<|>A review on the management of complications in patients receiving home parenteral nutrition was published by Howard L and Ashley C.)\n##\n(\"entity\"<|>PREDICTORS OF METABOLIC BONE DISEASE<|>EVENT<|>The predictors of metabolic bone disease in pediatric intestinal failure were studied by Demehri FR et al.)\n##\n(\"entity\"<|>INCIDENCE, PREVENTION, AND TREATMENT<|>EVENT<|>The incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children were reviewed by Lauriti G et al.)\n##\n(\"entity\"<|>PREVALENCE OF LIVER COMPLICATIONS<|>EVENT<|>The prevalence of liver complications in children receiving long-term parenteral nutrition was studied by Peyret B et al.)\n##\n(\"entity\"<|>NUTRITION HOSPITAL<|>ORGANIZATION<|>Nutrition Hospital publishes articles on various aspects of nutrition and parenteral nutrition.)\n##\n(\"entity\"<|>JPEN J PARENTERAL ENTERAL NUTRITION<|>ORGANIZATION<|>JPEN J Parenteral Enteral Nutrition is a journal that publishes research on parenteral nutrition.)\n##\n(\"relationship\"<|>NUTRITIONAL FACTORS<|>LONG-TERM OUTCOME<|>Nutritional factors are linked to the long-term outcome of children receiving home parenteral nutrition<|>5)\n##\n(\"relationship\"<|>SYSTEMATIC REVIEW<|>HEPARIN-CONTROLLED PROSPECTIVE TRIAL<|>The systematic review on parenteral nutrition-associated cholestasis includes findings from the heparin-controlled prospective trial<|>6)\n##\n(\"relationship\"<|>CASE SERIES<|>SYSTEMATIC REVIEW<|>The case series on central venous catheter thrombosis contributes to the systematic review on related complications<|>5)\n##\n(\"relationship\"<|>REVIEW<|>PREDICTORS OF METABOLIC BONE DISEASE<|>The review on management of complications includes discussions on predictors of metabolic bone disease<|>6)\n##\n(\"relationship\"<|>INCIDENCE, PREVENTION, AND TREATMENT<|>PREVALENCE OF LIVER COMPLICATIONS<|>The review on incidence, prevention, and treatment discusses the prevalence of liver complications in children<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . Janum S, Zingg W, Classsen V, Afshari A. Bench-to-bedside review: challenges of diagnosis, care and prevention of central catheter-realted bloodstream infections in children. Crit Care. 2013; 28:238.\n\n73. Germán Díaz M, Moreno Villares JM; Gomis Muñoz P, León Sanz M. Sellado con antibióticos o antisépticos en pacientes pediátricos con nutrición parenteral domiciliaria. Puesta al día. Nutr Hosp. 2016; 33:771-81.\n\n74. Wong T, Clifford V, McCallum Z, et al. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition: A case series. JPEN J Parenter Enteral Nutr. 2011; 36:358-60.\n\n75. Bisseling TM, Willems MC, Versleijen MW, et al. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: A heparin-controlled prospective trial. Clin Nutr. 2010; 29(4):464-8.\n\n76. Howard L, Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology. 2003; 124:1651-61.\n\n77. Byrnes MC, Stangenes J. Refeeding in the ICU: an adult and pediatric problem. Curr Opin Clin Nutr Metab Care. 2011; 14:186-92.\n\n78. Crook MA, Hally V, Pantelli JV. The importance of the refeeding syndrome. Nutrition 2001; 17:632-7.\n\n79. Demehri FR, Simha S, Stephensa L, Harris MB, Arnold MA, Brown PI, Teitelbaum DH. Pediatric intestinal failure: predictors of metabolic bone disease. J Pediatr Surg. 2015; 50:958-62.\n\n80. Blanca García JA, Moráis López AB, Cortes Mora P. Afectación hepática y ósea asociadas a nutrición parenteral. Acta Pediatr Esp. 2016; 74:160-164.\n\n81. Lauriti G, Zani A, Aufieri R, Cananzi M, Chiesa PL, Eaton S, Pierro A. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr. 2014; 38:70-85.\n\n82. Rangel SJ, Calkins CM, Cowles RA, Barnhart DC, Huang EY, Abdullah F et al. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2012; 47:225-40.\n\n83. Btaiche IF, Khalidi N. Metabolic complications of parenteral nutrition in adults, part 2. Am J Health-SystPharm. 2004;61:2050-7; quiz 2058-9. Review. Erratum in: Am J Health Syst Pharm. 2004; 61:2616.\n\n84. Peyret B, Collardeau S, Touzet S, Loras-Duclaux I, Yantren H, Michalski MC, et al. Prevalence of liver complications in children receiving long-term parenteral nutrition. Eur J Clin Nutr. 2011 Jun; 65:743-9.\n\n85. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr. 2003; 50:245-67.\n\n86. Mangalat N, Bell C, Graves A, Imseis EM. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation. BMC Pediatr. 2014; 14:298.\n\n87. Wales PW, Allen N, Worthington P, George D, Compher C; American Society for Parenteral and Enteral Nutrition, A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2014; 38:538-57.\n\n88. Pedrón-Giner C, Martínez-Costa C, Gómez-López L, Navas-López VM, Redecillas Ferreiro S, Moreno-Villares JM, et al. Home parenteral nutrition in children: procedures, experiences and reflections. Nutr Hosp. 2010; 25:705-11.\n\n89. Colomb V, Dabbas-Tyan M, Taupin P, Talbotec C, Révillon Y, Jan D, et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr. 2007 Mar; 44:347-53.\n\n90. Norman JL, Crill CM. Optimizing the transition to home parenteral nutrition in pediatric patients. Nutr Clin Pract. 2011; 26(3):273-85.\n---\nThe image appears to be a blank white page. There is no visible content, text, diagrams, or any other information present in this image. Therefore, I cannot provide any markdown translation or description of content, as there is nothing to transcribe or\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>JANUM S<|>PERSON<|>Janum S is an author who contributed to a review on central catheter-related bloodstream infections in children.)\n##\n(\"entity\"<|>ZINGG W<|>PERSON<|>Zingg W is an author who contributed to a review on central catheter-related bloodstream infections in children.)\n##\n(\"entity\"<|>CLASSEN V<|>PERSON<|>Classsen V is an author who contributed to a review on central catheter-related bloodstream infections in children.)\n##\n(\"entity\"<|>AFSHARI A<|>PERSON<|>Afshari A is an author who contributed to a review on central catheter-related bloodstream infections in children.)\n##\n(\"entity\"<|>GERMÁN DÍAZ M<|>PERSON<|>Germán Díaz M is an author who wrote about antibiotic sealing in pediatric patients with home parenteral nutrition.)\n##\n(\"entity\"<|>MORENO VILLARES JM<|>PERSON<|>Moreno Villares JM is an author who wrote about antibiotic sealing in pediatric patients with home parenteral nutrition.)\n##\n(\"entity\"<|>GOMIS MUÑOZ P<|>PERSON<|>Gomis Muñoz P is an author who wrote about antibiotic sealing in pediatric patients with home parenteral nutrition.)\n##\n(\"entity\"<|>LEÓN SANZ M<|>PERSON<|>León Sanz M is an author who wrote about antibiotic sealing in pediatric patients with home parenteral nutrition.)\n##\n(\"entity\"<|>WONG T<|>PERSON<|>Wong T is an author who reported on central venous catheter thrombosis in pediatric patients.)\n##\n(\"entity\"<|>CLIFFORD V<|>PERSON<|>Clifford V is an author who reported on central venous catheter thrombosis in pediatric patients.)\n##\n(\"entity\"<|>MCCALLUM Z<|>PERSON<|>McCallum Z is an author who reported on central venous catheter thrombosis in pediatric patients.)\n##\n(\"entity\"<|>BISSELING TM<|>PERSON<|>Bisseling TM is an author who conducted a trial on taurolidine lock effectiveness in preventing infections.)\n##\n(\"entity\"<|>WILLEMS MC<|>PERSON<|>Willems MC is an author who conducted a trial on taurolidine lock effectiveness in preventing infections.)\n##\n(\"entity\"<|>VERSLEIJEN MW<|>PERSON<|>Versleijen MW is an author who conducted a trial on taurolidine lock effectiveness in preventing infections.)\n##\n(\"entity\"<|>HOWARD L<|>PERSON<|>Howard L is an author who discussed management of complications in patients receiving home parenteral nutrition.)\n##\n(\"entity\"<|>ASHLEY C<|>PERSON<|>Ashley C is an author who discussed management of complications in patients receiving home parenteral nutrition.)\n##\n(\"entity\"<|>BYRNES MC<|>PERSON<|>Byrnes MC is an author who wrote about refeeding in the ICU for adults and pediatrics.)\n##\n(\"entity\"<|>STANGENES J<|>PERSON<|>Stangenes J is an author who wrote about refeeding in the ICU for adults and pediatrics.)\n##\n(\"entity\"<|>CROOK MA<|>PERSON<|>Crook MA is an author who emphasized the importance of refeeding syndrome.)\n##\n(\"entity\"<|>HALLY V<|>PERSON<|>Hally V is an author who emphasized the importance of refeeding syndrome.)\n##\n(\"entity\"<|>PANTELLI JV<|>PERSON<|>Pantelli JV is an author who emphasized the importance of refeeding syndrome.)\n##\n(\"entity\"<|>DEMEHRI FR<|>PERSON<|>Demehri FR is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>SIMHA S<|>PERSON<|>Simha S is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>STEPHENSA L<|>PERSON<|>Stephensa L is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>HARRIS MB<|>PERSON<|>Harris MB is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>ARNOLD MA<|>PERSON<|>Arnold MA is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>BROWN PI<|>PERSON<|>Brown PI is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>TEITELBAUM DH<|>PERSON<|>Teitelbaum DH is an author who studied predictors of metabolic bone disease in pediatric intestinal failure.)\n##\n(\"entity\"<|>BLANCA GARCÍA JA<|>PERSON<|>Blanca García JA is an author who wrote about liver and bone affections associated with parenteral nutrition.)\n##\n(\"entity\"<|>MORÁS LÓPEZ AB<|>PERSON<|>Moráis López AB is an author who wrote about liver and bone affections associated with parenteral nutrition.)\n##\n(\"entity\"<|>CORTES MORA P<|>PERSON<|>Cortes Mora P is an author who wrote about liver and bone affections associated with parenteral nutrition.)\n##\n(\"entity\"<|>LAURITI G<|>PERSON<|>Lauriti G is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>ZANI A<|>PERSON<|>Zani A is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>AUFIERI R<|>PERSON<|>Aufieri R is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>CANANZI M<|>PERSON<|>Cananzi M is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>CHIESA PL<|>PERSON<|>Chiesa PL is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>EATON S<|>PERSON<|>Eaton S is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>PIERRO A<|>PERSON<|>Pierro A is an author who reviewed incidence, prevention, and treatment of liver disease in infants and children.)\n##\n(\"entity\"<|>RANGEL SJ<|>PERSON<|>Rangel SJ is an author who conducted a systematic review on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>CALKINS CM<|>PERSON<|>Calkins CM is an author who conducted a systematic review on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>COWLES RA<|>PERSON<|>Cowles RA is an author who conducted a systematic review on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>BARNHART DC<|>PERSON<|>Barnhart DC is an author who conducted a systematic review on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>HUANG EY<|>PERSON<|>Huang EY is an author who conducted a systematic review on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>ABDULLAH F<|>PERSON<|>Abdullah F is an author who conducted a systematic review on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>BTAICHE IF<|>PERSON<|>Btaiche IF is an author who wrote about metabolic complications of parenteral nutrition in adults.)\n##\n(\"entity\"<|>KHALIDI N<|>PERSON<|>Khalidi N is an author who wrote about metabolic complications of parenteral nutrition in adults.)\n##\n(\"entity\"<|>PEYRET B<|>PERSON<|>Peyret B is an author who studied liver complications in children receiving long-term parenteral nutrition.)\n##\n(\"entity\"<|>COLLARDEAU S<|>PERSON<|>Collardeau S is an author who studied liver complications in children receiving long-term parenteral nutrition.)\n##\n(\"entity\"<|>TOUZET S<|>PERSON<|>Touzet S is an author who studied liver complications in children receiving long-term parenteral nutrition.)\n##\n(\"entity\"<|>LORAS-DUCLAUX I<|>PERSON<|>Loras-Duclaux I is an author who studied liver complications in children receiving long-term parenteral nutrition.)\n##\n(\"entity\"<|>YANTRON H<|>PERSON<|>Yantren H is an author who studied liver complications in children receiving long-term parenteral nutrition.)\n##\n(\"entity\"<|>MICHALSKI MC<|>PERSON<|>Michalski MC is an author who studied liver complications in children receiving long-term parenteral nutrition.)\n##\n(\"entity\"<|>FORCHIELLI ML<|>PERSON<|>Forchielli ML is an author who discussed nutritional factors contributing to cholestasis during total parenteral nutrition.)\n##\n(\"entity\"<|>WALKER WA<|>PERSON<|>Walker WA is an author who discussed nutritional factors contributing to cholestasis during total parenteral nutrition.)\n##\n(\"entity\"<|>MANGALAT N<|>PERSON<|>Mangalat N is an author who studied bilirubin trajectory in neonates after parenteral nutrition cessation.)\n##\n(\"entity\"<|>BELL C<|>PERSON<|>Bell C is an author who studied bilirubin trajectory in neonates after parenteral nutrition cessation.)\n##\n(\"entity\"<|>GRAVES A<|>PERSON<|>Graves A is an author who studied bilirubin trajectory in neonates after parenteral nutrition cessation.)\n##\n(\"entity\"<|>IMSEIS EM<|>PERSON<|>Imseis EM is an author who studied bilirubin trajectory in neonates after parenteral nutrition cessation.)\n##\n(\"entity\"<|>WALES PW<|>PERSON<|>Wales PW is an author who contributed to clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>ALLEN N<|>PERSON<|>Allen N is an author who contributed to clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>WORTHINGTON P<|>PERSON<|>Worthington P is an author who contributed to clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>GEORGE D<|>PERSON<|>George D is an author who contributed to clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>COMPHER C<|>PERSON<|>Compher C is an author who contributed to clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The American Society for Parenteral and Enteral Nutrition provides clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>A.S.P.E.N.<|>ORGANIZATION<|>A.S.P.E.N. is an organization that provides clinical guidelines for pediatric patients with intestinal failure.)\n##\n(\"entity\"<|>PEDIATRIC SURGICAL ASSOCIATION<|>ORGANIZATION<|>The American Pediatric Surgical Association conducts systematic reviews on parenteral nutrition-associated cholestasis.)\n##\n(\"entity\"<|>NUTRITION HOSPITAL<|>ORGANIZATION<|>Nutrition Hospital publishes articles on various aspects of nutrition and parenteral nutrition.)\n##\n(\"entity\"<|>JPEN J PARENTERAL ENTERAL NUTRITION<|>ORGANIZATION<|>JPEN J Parenteral Enteral Nutrition is a journal that publishes research on parenteral nutrition.)\n##\n(\"relationship\"<|>JANUM S<|>ZINGG W<|>Janum S and Zingg W co-authored a review on central catheter-related bloodstream infections in children<|>7)\n##\n(\"relationship\"<|>JANUM S<|>CLASSEN V<|>Janum S and Classsen V co-authored a review on central catheter-related bloodstream infections in children<|>7)\n##\n(\"relationship\"<|>JANUM S<|>AFSHARI A<|>Janum S and Afshari A co-authored a review on central catheter-related bloodstream infections in children<|>7)\n##\n(\"relationship\"<|>ZINGG W<|>CLASSEN V<|>Zingg W and Classsen V co-authored a review on central catheter-related bloodstream infections in children<|>7)\n##\n(\"relationship\"<|>ZINGG W<|>AFSHARI A<|>Zingg W and Afshari A co-authored a review on central catheter-related bloodstream infections in children<|>7)\n##\n(\"relationship\"<|>CLASSEN V<|>AFSHARI A<|>Classsen V and Afshari A co-authored a review on central catheter-related bloodstream infections in children<|>7)\n##\n(\"relationship\"<|>GERMÁN DÍAZ M<|>MORENO VILLARES JM<|>Germán Díaz M and Moreno Villares JM co-authored a paper on antibiotic sealing in pediatric patients<|>7)\n##\n(\"relationship\"<|>GERMÁN DÍAZ M<|>GOMIS MUÑOZ P<|>Germán Díaz M and Gomis Muñoz P co-authored a paper on antibiotic sealing in pediatric patients<|>7)\n##\n(\"relationship\"<|>GERMÁN DÍAZ M<|>LEÓN SANZ M<|>Germán Díaz M and León Sanz M co-authored a paper on antibiotic sealing in pediatric patients<|>7)\n##\n(\"relationship\"<|>MORENO VILLARES JM<|>GOMIS MUÑOZ P<|>Moreno Villares JM and Gomis Muñoz P co-authored a paper on antibiotic sealing in pediatric patients<|>7)\n##\n(\"relationship\"<|>MORENO VILLARES JM<|>LEÓN SANZ M<|>Moreno Villares JM and León Sanz M co-authored a paper on antibiotic sealing in pediatric patients<|>7)\n##\n(\"relationship\"<|>GOMIS MUÑOZ P<|>LEÓN SANZ M<|>Gomis Muñoz P and León Sanz M co-authored a paper on antibiotic sealing in pediatric patients<|>7)\n##\n(\"relationship\"<|>WONG T<|>CLIFFORD V<|>Wong T and Clifford V co-authored a report on central venous catheter thrombosis in pediatric patients<|>7)\n##\n(\"relationship\"<|>WONG T<|>MCCALLUM Z<|>Wong T and McCallum Z co-authored a report on central venous catheter thrombosis in pediatric patients<|>7)\n##\n(\"relationship\"<|>CLIFFORD V<|>MCCALLUM Z<|>Clifford V and McCallum Z co-authored a report on central venous catheter thrombosis in pediatric patients<|>7)\n##\n(\"relationship\"<|>BISSELING TM<|>WILLEMS MC<|>Bisseling TM and Willems MC co-authored a trial on taurolidine lock effectiveness<|>7)\n##\n(\"relationship\"<|>BISSELING TM<|>VERSLEIJEN MW<|>Bisseling TM and Versleijen MW co-authored a trial on taurolidine lock effectiveness<|>7)\n##\n(\"relationship\"<|>BISSELING TM<|>HOWARD L<|>Bisseling TM and Howard L co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>BISSELING TM<|>ASHLEY C<|>Bisseling TM and Ashley C co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>WILLEMS MC<|>VERSLEIJEN MW<|>Willems MC and Versleijen MW co-authored a trial on taurolidine lock effectiveness<|>7)\n##\n(\"relationship\"<|>WILLEMS MC<|>HOWARD L<|>Willems MC and Howard L co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>WILLEMS MC<|>ASHLEY C<|>Willems MC and Ashley C co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>VERSLEIJEN MW<|>HOWARD L<|>Versleijen MW and Howard L co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>VERSLEIJEN MW<|>ASHLEY C<|>Versleijen MW and Ashley C co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>HOWARD L<|>ASHLEY C<|>Howard L and Ashley C co-authored a paper on management of complications in home parenteral nutrition<|>7)\n##\n(\"relationship\"<|>BYRNES MC<|>STANGENES J<|>Byrnes MC and Stangenes J co-authored a paper on refeeding in the ICU<|>7)\n##\n(\"relationship\"<|>CROOK MA<|>HALLY V<|>Crook MA and Hally V co-authored a paper on the importance of refeeding syndrome<|>7)\n##\n(\"relationship\"<|>CROOK MA<|>PANTELLI JV<|>Crook MA and Pantelli JV co-authored a paper on the importance of refeeding syndrome<|>7)\n##\n(\"relationship\"<|>HALLY V<|>PANTELLI JV<|>Hally V and Pantelli JV co-authored a paper on the importance of refeeding syndrome<|>7)\n##\n(\"relationship\"<|>DEMEHRI FR<|>SIMHA S<|>Demehri FR and Simha S co-authored a study on metabolic bone disease"}]}